Table 3.
Multivariable competing risks analysis for ICU admission.
| Risk factors | ICU admission, adjusted cause-specific HR (95% CI) | ICU admission, adjusted subdistribution HR (95% CI) |
|---|---|---|
| Age (per year) | 0.949 (0.900–1.002) | 0.949 (0.892–1.011) |
| Male sex | 0.56 (0.163–1.922) | 0.535 (0.143–2.004) |
| Any comorbidity | 0.482 (0.093–2.513) | 0.424 (0.059–3.031) |
| ACEi/ARB use | 0.707 (0.204–2.448) | 0.791 (0.256–2.44) |
| CKD | 0.675 (0.178–2.569) | 0.744 (0.358–1.546) |
| AKI | 2.759 (0.613–12.413) | 2.461 (0.588–10.3) |
| Lymphocyte percentage (per point)a | 0.819 (0.701–0.958) | 0.831 (0.728–0.949) |
| C-reactive protein (per mg/l)a | 0.997 (0.991–1.003) | 0.996 (0.991–1.001) |
| COVID-19 severity (per grade)a | 33.2238 (4.711–234.512) | 23.47 (1.374–401.019) |
| Lopinavir/Ritonavir | 8.678 (0.936–80.433) | 9.437 (0.869–102.537) |
AKI, acute kidney injury; CI, confidence interval; CKD, chronic kidney disease; COVID-19, Coronavirus disease-19; HR, Hazard ratio.
a
On admission.